BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 10891433)

  • 1. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy.
    Harmatz P; Butensky E; Quirolo K; Williams R; Ferrell L; Moyer T; Golden D; Neumayr L; Vichinsky E
    Blood; 2000 Jul; 96(1):76-9. PubMed ID: 10891433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
    Brown K; Subramony C; May W; Megason G; Liu H; Bishop P; Walker T; Nowicki MJ
    J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
    Badawy SM; Liem RI; Rigsby CK; Labotka RJ; DeFreitas RA; Thompson AA
    Br J Haematol; 2016 Nov; 175(4):705-713. PubMed ID: 27507431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
    Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
    Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of iron overload in sickle cell disease.
    Olivieri NF
    Semin Hematol; 2001 Jan; 38(1 Suppl 1):57-62. PubMed ID: 11206962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Iron overload in sickle cell anemia : a study of 94 patients].
    Hafsia R; Belakhal F; Ben Salah N; Gouider E; Elborgi W
    Tunis Med; 2011 Jun; 89(6):548-52. PubMed ID: 21681718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gaps in the diagnosis and management of iron overload in sickle cell disease: a 'real-world' report from the GRNDaD registry.
    Wilson SR; Sears M; Williams E; Drapekin J; Sivakumar I; Padrino S; Desai PC; Hager W; Manwani D; Clay LJ; Field JJ; Kanter J; Cohen AJ; Saif Ur Rehman S; Lanzkron S; Little JA;
    Br J Haematol; 2021 Dec; 195(5):e157-e160. PubMed ID: 34423416
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver biopsy results in patients with sickle cell disease on chronic transfusions: poor correlation with ferritin levels.
    Karam LB; Disco D; Jackson SM; Lewin D; McKie V; Baker RD; Baker SS; Laver JH; Nietert PJ; Abboud MR
    Pediatr Blood Cancer; 2008 Jan; 50(1):62-5. PubMed ID: 17457853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
    Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
    Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusional Iron Overload in a Cohort of Children with Sickle Cell Disease: Impact of Magnetic Resonance Imaging, Transfusion Method, and Chelation.
    Stanley HM; Friedman DF; Webb J; Kwiatkowski JL
    Pediatr Blood Cancer; 2016 Aug; 63(8):1414-8. PubMed ID: 27100139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
    Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
    J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferritin and LIC: predicting liver injury in children with sickle cell.
    Smith E; Lebensburger J; Hilliard L; Kelly D; Fineberg N; Bai S; Howard T
    J Pediatr Gastroenterol Nutr; 2014 Mar; 58(3):387-90. PubMed ID: 24553473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deferasirox for managing transfusional iron overload in people with sickle cell disease.
    Meerpohl JJ; Antes G; Rücker G; Fleeman N; Niemeyer C; Bassler D
    Cochrane Database Syst Rev; 2010 Aug; (8):CD007477. PubMed ID: 20687088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention.
    Kwiatkowski JL; Cohen AR; Garro J; Alvarez O; Nagasubramanian R; Sarnaik S; Thompson A; Woods GM; Schultz W; Mortier N; Lane P; Mueller B; Yovetich N; Ware RE;
    Am J Hematol; 2012 Feb; 87(2):221-3. PubMed ID: 22120913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions.
    Fung EB; Harmatz PR; Milet M; Balasa V; Ballas SK; Casella JF; Hilliard L; Kutlar A; McClain KL; Olivieri NF; Porter JB; Vichinsky EP;
    Transfusion; 2008 Sep; 48(9):1971-80. PubMed ID: 18513257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP).
    Files B; Brambilla D; Kutlar A; Miller S; Vichinsky E; Wang W; Granger S; Adams RJ
    J Pediatr Hematol Oncol; 2002 May; 24(4):284-90. PubMed ID: 11972097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences and management of iron overload in sickle cell disease.
    Porter J; Garbowski M
    Hematology Am Soc Hematol Educ Program; 2013; 2013():447-56. PubMed ID: 24319218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased complications of chronic erythrocytapheresis compared with manual exchange transfusions in children and adolescents with sickle cell disease.
    Woods D; Hayashi RJ; Binkley MM; Sparks GW; Hulbert ML
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28544309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury.
    Adamkiewicz TV; Abboud MR; Paley C; Olivieri N; Kirby-Allen M; Vichinsky E; Casella JF; Alvarez OA; Barredo JC; Lee MT; Iyer RV; Kutlar A; McKie KM; McKie V; Odo N; Gee B; Kwiatkowski JL; Woods GM; Coates T; Wang W; Adams RJ
    Blood; 2009 Nov; 114(21):4632-8. PubMed ID: 19721013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
    Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.